In particular, we focus on issues of confounding, randomization, nature of inference, single- versus multiple-trait modeling, cow- versus herd-level modeling, and scope of inference, all within the context of dairy production systems.
In addition, ethical issues on randomization have been described [ 12].
The authors of the Cochrane review emphasize that new trials must take into account important issues like methods of randomization, blinding and duration of follow-up, as well as standard and validated outcome measures, patient assessed functional outcomes and resource use assessments.
This study investigates the health effects of also addressing the remaining risk factor, lack of knowledge about important health issues, through randomization of members of a microcredit organization to receive a health education module based on the World Health Organization's Integrated Management of Childhood Illness (IMCI) community intervention.
The key elements of comparative clinical trial design include issues of enrolment, stratification, randomization, blinding, administration of study drugs, monitoring of drug toxicity, definitions, and key statistical elements of end points, sample size, and tools for data analysis.
However, our study shares the disadvantages of most retrospective studies, including missing data issues [ 43], lack of randomization, and a potential for model misspecification.
Since ethical issues surrounding randomization of the individual pregnant woman for a Q fever screening or non-screening strategy could seriously threaten approval by an ethics committee, we designed a clustered randomized controlled trial in which primary care midwife centres are randomized to recruit either pregnant women for the control group or for the intervention group.
A related issue pertained to the timing of randomization, which was partially determined by the review process.
The discussions include the issues in randomization and study design, comparison of randomized experimental studies to nonrandomized observational studies, and the difficulties of nonrandomized experimental studies.
The major quality issues with the RCTs were inadequate description of randomization processes in about half the studies, no reports of double blinding in a majority of the studies, and no discussion of methods to assess harms in most studies.
